1 – 10 of 197
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Primary glomerular diseases and long-term adverse health outcomes : A nationwide cohort study
(
- Contribution to journal › Article
-
Mark
Long-term Outcomes of Lupus Nephritis in Comparison to Other CKD Etiologies
(
- Contribution to journal › Article
-
Mark
Efficacy and Safety of Rituximab in Antiglomerular Basement Membrane Disease
(
- Contribution to journal › Article
-
Mark
IgA vasculitis nephritis - outcomes in adult-onset disease
(
- Contribution to journal › Article
- 2024
-
Mark
A population-based study on the incidence and aetiology of infectious complications in peritoneal dialysis in South Sweden
(
- Contribution to journal › Article
-
Mark
EULAR recommendations for the management of ANCA-associated vasculitis : 2022 update
(
- Contribution to journal › Article
-
Mark
Evaluation of the ACR/EULAR 2022 criteria for classification of ANCA-associated vasculitis in a population-based cohort from Sweden
(
- Contribution to journal › Article
-
Mark
Using imlifidase to elucidate the characteristics and importance of anti-GBM antibodies produced after start of treatment
2024) In Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 39(1). p.45-54(
- Contribution to journal › Article
-
Mark
Changes in the epidemiology of kidney replacement therapy across Europe in 2020 - The first year of the COVID-19 pandemic : An ERA Registry study
(
- Contribution to journal › Article
-
Mark
Incidence and outcomes of kidney replacement therapy for end-stage kidney disease due to primary glomerular disease in Europe : findings from the ERA Registry
(
- Contribution to journal › Article